87 related articles for article (PubMed ID: 1705382)
21. Modulation of mesangial cell contraction by arachidonate metabolites.
Mené P; Dunn MJ
Trans Assoc Am Physicians; 1986; 99():125-31. PubMed ID: 3111059
[No Abstract] [Full Text] [Related]
22. Effects of leukotriene D4 on large and small coronary arteries in the conscious dog.
Hintze TH; Stern H; Kaley G
Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():287-98. PubMed ID: 2949554
[No Abstract] [Full Text] [Related]
23. Cytochrome P450 arachidonic acid epoxygenase: stereochemical characterization of epoxyeicosatrienoic acids.
Capdevila JH; Dishman E; Karara A; Falck JR
Methods Enzymol; 1991; 206():441-53. PubMed ID: 1784229
[No Abstract] [Full Text] [Related]
24. Cytochrome P450-dependent arachidonate metabolites, renal function and blood pressure regulation.
McGiff JC; Carroll MA
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():675-82. PubMed ID: 1847570
[No Abstract] [Full Text] [Related]
25. Platelet prostanoids in interaction of platelets with collagen substrates. II. Effects of exogenous arachidonic acid, stable PG endoperoxides analogue, and aspirin.
Mazurov AV; Leytin VL; Repin VS; Taube C; Förster W
Biomed Biochim Acta; 1984; 43(8-9):S373-6. PubMed ID: 6440553
[TBL] [Abstract][Full Text] [Related]
26. Increased response to arachidonic acid and U-46619 and resistance to inhibitory prostaglandins in patients with chronic myeloproliferative disorders.
Cortelazzo S; Galli M; Castagna D; Viero P; de Gaetano G; Barbui T
Thromb Haemost; 1988 Feb; 59(1):73-6. PubMed ID: 3129810
[TBL] [Abstract][Full Text] [Related]
27. Modification of arachidonic acid metabolism via the cytochrome P450-related monooxygenase system.
Schwartzman ML
Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():241-9. PubMed ID: 2169180
[No Abstract] [Full Text] [Related]
28. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
29. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
Lévy-Toledano S; Grelac F; Caen JP; Maclouf J
Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416
[TBL] [Abstract][Full Text] [Related]
30. Thromboxane synthesis and actions in isolated adrenergic nerve (pheochromocytoma-12) cells.
Trachte GJ; Hook PJ; Kemp JR; Acosta EP; Ziegler RJ
J Pharmacol Exp Ther; 1988 Oct; 247(1):43-6. PubMed ID: 3139869
[TBL] [Abstract][Full Text] [Related]
31. U-46619, a stable analogue of prostaglandin H2, induces retraction of human platelet-rich plasma clots.
Bertelé V; Di Minno G; de Gaetano G
Thromb Res; 1980 May 1-15; 18(3-4):543-5. PubMed ID: 6774436
[No Abstract] [Full Text] [Related]
32. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
Patscheke H; Stegmeier K; Müller-Beckmann B; Sponer G; Staiger C; Neugebauer G
Biomed Biochim Acta; 1984; 43(8-9):S312-8. PubMed ID: 6097235
[TBL] [Abstract][Full Text] [Related]
33. Desensitisation in human and rabbit blood platelets.
Hallam TJ; Ruggles PA; Scrutton MC; Wallis RB
Thromb Haemost; 1982 Jun; 47(3):278-84. PubMed ID: 7112500
[No Abstract] [Full Text] [Related]
34. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase.
Brüne B; Ullrich V
Mol Pharmacol; 1987 Oct; 32(4):497-504. PubMed ID: 2890093
[TBL] [Abstract][Full Text] [Related]
35. Study of tachyphylaxis to the vasoconstrictor effect of arachidonic acid in the isolated perfused kidney of the rat.
Quilley J; McGiff JC
J Pharmacol Exp Ther; 1990 Jan; 252(1):241-5. PubMed ID: 2105392
[TBL] [Abstract][Full Text] [Related]
36. Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation.
Behm DJ; Ogbonna A; Wu C; Burns-Kurtis CL; Douglas SA
J Pharmacol Exp Ther; 2009 Jan; 328(1):231-9. PubMed ID: 18836067
[TBL] [Abstract][Full Text] [Related]
37. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy.
Horn EH; Hardy E; Cooper J; Heptinstall S; Rubin PC
Thromb Haemost; 1996 Feb; 75(2):346-51. PubMed ID: 8815588
[TBL] [Abstract][Full Text] [Related]
38. Regulation of leukotriene C4 synthase in human platelets via receptor-mediated mechanisms.
Edenius C; Tornhamre S; Näsman-Glaser B; Eriksson I; Björkholm S; Lindgren JA
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():333-5. PubMed ID: 7732865
[No Abstract] [Full Text] [Related]
39. Suppression of lymphatic vessel contractility with inhibitors of arachidonic acid metabolism.
Johnston MG; Feuer C
J Pharmacol Exp Ther; 1983 Aug; 226(2):603-7. PubMed ID: 6410049
[TBL] [Abstract][Full Text] [Related]
40. Arachidonic acid epoxygenase: detection of epoxyeicosatrienoic acids in human urine.
Toto R; Siddhanta A; Manna S; Pramanik B; Falck JR; Capdevila J
Biochim Biophys Acta; 1987 Jun; 919(2):132-9. PubMed ID: 3580381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
